23 May 2013
Keywords: Nycomed, Roche, Takeda, Bonviva, Osteoporosis, Asia-Pacific markets
Article | 16 June 2011
Independent Swiss drugmaker Nycomed says that it has completed the transfer of marketing authorization approvals in a number of key ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 June 2011
15 June 2011
© 2013 thepharmaletter.com